Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools
2007

Reproducibility of a Breast Cancer Gene Expression Test

Sample size: 4 publication Evidence: high

Author Information

Author(s): Ach Robert A, Floore Arno, Curry Bo, Lazar Vladimir, Glas Annuska M, Pover Rob, Tsalenko Anya, Ripoche Hugues, Cardoso Fatima, Assignies Mahasti Saghatchian, Bruhn Laurakay, Van't Veer Laura J

Primary Institution: Agilent Laboratories

Hypothesis

What factors contribute to variability in gene expression measurements across different laboratories?

Conclusion

The study found that a specific breast cancer gene expression signature was highly reproducible across three laboratories despite some variability in the measurement process.

Supporting Evidence

  • The study used identical input RNA across all experiments.
  • RNA labeling was identified as the largest contributor to interlaboratory variation.
  • The results showed high intralaboratory and interlaboratory reproducibility.
  • Strictly controlled standard operating procedures were followed.

Takeaway

Scientists checked if a test for breast cancer worked the same way in different labs, and it did, which is good news for doctors and patients.

Methodology

The study involved comparing gene expression measurements from the same RNA samples processed in three different laboratories using standardized protocols.

Potential Biases

Inter-individual variability could not be fully separated from laboratory variability.

Limitations

The study could not measure every possible source of variation due to the experimental setup.

Participant Demographics

Total RNA from four breast tumors was used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2164-8-148

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication